Peptune

The Honest Guide to Peptides

There’s a lot of noise about peptides right now — miracle claims on one side, flat dismissals on the other. Peptune is the honest middle: what the evidence actually supports, what it doesn’t, and how to tell the difference — for recovery, midlife, and beyond.

Our one promise: no hype, and no fear-mongering. “Peptide” is one word covering wildly different things — from FDA-approved medications to unregulated gray-market products. Some have genuinely good evidence. Most don’t. We’ll always tell you which is which — and when the honest answer is “not yet.”

Our flagship: peptides in midlife

Peptune covers the whole peptide landscape — but the area we go deepest on, and the audience we serve most fully, is women navigating perimenopause and midlife. It’s where the hype is loudest, the stakes are real, and honest guidance is hardest to find. If that’s you, here’s the single most important idea we come back to.

Start with the order, not the molecule

If you take one thing from our midlife coverage, make it this: peptides are something you layer on top of a foundation that’s already working — not a shortcut past it. Get the order wrong and even a well-evidenced peptide is money and risk spent on the wrong thing. Here’s the sequence we come back to.

1

The foundation

Sleep, protein, strength training, stress, alcohol. Unglamorous, free, and the highest-leverage thing you can do in midlife. No peptide compensates for a missing foundation.

2

The hormones

For many women, hormone therapy is the layer that changes the most — and it’s the one most often skipped in favor of something newer. Emerging research even suggests hormones and certain peptides work better together. Settle this layer, with a clinician, before reaching ahead. Why order matters →

3

The peptides

Only here — foundation handled, hormones addressed — do peptides earn their place. And even then, only the ones with real evidence behind them. That’s what the rest of this site helps you tell apart.

The analogy worth remembering

Hormones are the floodlight; peptides are the spotlight. You bring the whole room up first — then aim the spotlight at what still needs it.

What actually has evidence (and what doesn’t)

“Peptide” is one word covering wildly different things — from FDA-approved medications to unregulated gray-market products. The label tells you nothing about whether something is safe or proven. Here’s the honest landscape across the uses people ask about most — recovery, metabolic health, skin, longevity, and hormones:

The regulatory picture is moving (as of June 2026): A U.S. FDA advisory committee is reviewing seven peptides — including BPC-157 — for compounding access at a hearing on July 23–24, 2026. Separately, the FDA has proposed removing GLP-1s from the outsourcing-facility list as the shortage resolves, which may affect compounded GLP-1 availability. A favorable vote is a milestone, not a green light — and every peptide reviewed in 2024 was turned down. We track this in The Peptune Brief each week.

Where to go from here

However you arrived, here’s the right next step depending on what you need. Our deepest library is on midlife and hormones today — our flagship — with more verticals on the way.

New here?

The Decision Guide

Our free, evidence-honest guide: which peptides have real evidence, which don’t, and the order that matters. The best place to start.

Get the guide →
Looking something up?

The Glossary

Plain-English definitions for every peptide, hormone, and clinical term you’ll run into — searchable, no jargon left unexplained.

Browse the glossary →
Going deep

GLP-1s for Perimenopause

The full evidence read on the best-studied option — what the trials show, the HRT-synergy research, and the honest caveats.

Read the breakdown →
Going deep

HRT and Peptides: What Order

The question almost nobody answers honestly — hormones first, or peptides? Why the sequence is the most important decision you’ll make.

Read the breakdown →
Going deep

GHK-Cu for Menopausal Skin

One of the few peptides with real evidence — what topical copper peptide actually does for midlife skin, and what’s oversold.

Read the breakdown →
Going deep

BPC-157, Honestly

The most-hyped, least-proven peptide of the bunch. What the human evidence actually shows — and why “not yet” is the honest answer.

Read the breakdown →
Quick answers

The FAQ

Straight answers to the questions people actually ask — safety, who shouldn’t take them, sourcing, cost, and where to start.

See the FAQ →
Every week

The Peptune Brief

The honest weekly read on what’s happening in peptides, hormones, and midlife. Read past issues, or subscribe free.

Read the Brief →
Every week

The Peptune Brief

The honest read on peptides, hormones, and midlife — delivered free, every week. Regulatory news, new research, and what it actually means for you, with the hype filtered out.

Subscribe free →

A note on why we do this

Peptides are being marketed harder than almost anything in health right now — for recovery, longevity, midlife, you name it — and the loudest voices are rarely the most honest. Peptune exists to be the adult in the room across all of it: to tell you when the evidence is strong, when it isn’t, and when the right answer is “not yet.” We go deepest on midlife and women’s health, where honest guidance is hardest to find — but the standard is the same everywhere we look. That’s less exciting than a miracle cure. It’s also the only approach that respects what you’re actually navigating.

Peptune

The no-hype read on peptides, hormones, and midlife — every week, free.

Get The Peptune Brief

This guide is educational and not medical advice. Peptides, hormone therapy, and GLP-1 medications carry real risks, interactions, and contraindications — always consult a qualified clinician before starting, stopping, or changing any treatment. Evidence and regulatory information are current as of June 2026 and may have changed since. Last updated: June 2026.